Free Trial

Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership

Enanta Pharmaceuticals logo
$6.28 +0.42 (+7.17%)
(As of 12/20/2024 05:16 PM ET)

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.64%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$306,026.21
Get ENTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ENTA Insider Buying and Selling by Quarter

Enanta Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/6/2024Jay R LulyCEOSell5,142$8.06$41,444.52  
12/6/2024Tara Lynn KiefferInsiderSell2,283$8.06$18,400.98  
7/15/2024Scott T RottinghausInsiderSell5,375$17.08$91,805.00  
7/11/2024Scott T RottinghausInsiderSell4,299$15.07$64,785.93  
6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.78  
(Data available from 1/1/2013 forward)

ENTA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Bruce L A Carter, Jay R Luly, Nathalie Adda, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA.

13.64% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings.

The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($1,371,575.34), Paul J Mellett ($755,876.76), Scott T Rottinghaus ($161,733.35), Tara Lynn Kieffer ($107,990.76), Terry Vance ($139,490.40), and Yat Sun Or ($618,966.25).

Insiders have sold a total of 109,238 Enanta Pharmaceuticals shares in the last 24 months for a total of $3,176,096.61 sold.

Enanta Pharmaceuticals Key Executives

  • Dr. Jay R. Luly Ph.D. (Age 68)
    President, CEO & Director
    Compensation: $1.25M
  • Mr. Paul J. Mellett Jr.Mr. Paul J. Mellett Jr. (Age 69)
    Chief Financial & Administrative Officer
    Compensation: $666.84k
  • Dr. Yat Sun Or Ph.D. (Age 72)
    Senior VP of Research & Development and Chief Scientific Officer
    Compensation: $729.31k
  • Mr. Nathaniel S. Gardiner J.D. (Age 70)
    Consultant
    Compensation: $672.67k
  • Mr. Brendan Luu (Age 49)
    Chief Business Officer
    Compensation: $622.86k
  • Ms. Jennifer Viera
    Senior Director of Investor Relations & Corporate Communications
  • Mr. Matthew P. Kowalsky J.D. (Age 51)
    Chief Legal Officer
  • Ms. Tara Lynn Kieffer Ph.D. (Age 46)
    Chief Product Strategy Officer
    Compensation: $496.85k
    1 recent trades
  • Dr. Scott T. Rottinghaus M.D. (Age 50)
    Senior VP & Chief Medical Officer
    Compensation: $616.73k
    2 recent trades


This page (NASDAQ:ENTA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners